CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
PARAOXONASE-1 AND EARLY LIFE ENVIRONMENTAL EXPOSURES
-
2016 Jan-Feb
-
Source: Ann Glob Health. 82(1):100-110
Details:
-
Alternative Title:Ann Glob Health
-
Personal Author:
-
Description:Background
Acute and chronic exposures to widely used organophosphorus (OP) insecticides are common. Children’s detoxification mechanisms are not well developed until several years after birth. The increased cases of neurodevelopmental disorders in children, together with their increased susceptibility to OP neurotoxicity cannot be explained by genetic factors alone but could be related to gene-environment interactions. Paraoxonase-1 (PON1) is an enzyme that can detoxify OPs but its catalytic efficiency for hydrolysis to certain OPs is modulated by the Q192R polymorphism.
Findings
Studies in animals have provided important information on the role of PON1 in protecting against gestational and postnatal toxicity to OPs. The PON1Q192 allele is less efficient hydrolyzing certain OPs than the PON1R192 allele. Maternal PON1 status (PON1 activity levels, the most important measurement, and functional Q192R phenotype) modulates the detrimental effects of exposure to the OP chlorpyrifos oxon on fetal brain gene expression and biomarkers of exposure. Epidemiological studies suggest that children from mothers with lower PON1 status that were in contact with OPs during pregnancy tend to show smaller head circumference at birth and adverse effects in cognitive function during childhood.
Conclusion
Infants and children are vulnerable to OP toxicity. The detrimental consequences of OPs on neurodevelopment can lead to future generations with permanent cognitive problems and susceptibility to develop neurodegenerative diseases. Improved methods using mass spectrometry to monitor OP-adducted biomarker proteins are needed and will be extremely helpful in early life biomonitoring, while measurement of PON1 status as a biomarker of susceptibility will help identify mothers and children highly sensitive to OPs. The use of adductomics instead of enzymatic activity assays for biomonitoring OP exposures have proved to provide several advantages, including the use of dried blood spots, which would facilitate monitoring newborn babies and children.
-
Subjects:
-
Source:
-
Pubmed ID:27325068
-
Pubmed Central ID:PMC4916371
-
Document Type:
-
Funding:
-
Volume:82
-
Issue:1
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: